EcoDrugPlus

Androgen Receptor

Ensembl ID : ENSKMAG00000016405
Gene Symbol: LOC108237972
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSKMAG00000011672
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Apelin Receptor B-Like

Ensembl ID : ENSKMAG00000013411
Gene Symbol: LOC108248823
3 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSKMAG00000021168
Gene Symbol: APH1A
3 Cross references
190 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSKMAG00000021171
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSKMAG00000007130
Gene Symbol: LOC108242243
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSKMAG00000004642
Gene Symbol: ALOX5
3 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSKMAG00000006513
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSKMAG00000001407
Gene Symbol: AVPR1A
1 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSKMAG00000017083
Gene Symbol: AVPR1AB
1 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSKMAG00000005823
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSKMAG00000019356
Gene Symbol: AVPR2
3 Cross references
148 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).